Economic portfolio
Mirae Asset Healthcare Fund
MIRAE Mirae Asset Mutual Fund Mar 2026 — Sep 2026 7 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 4.2 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
7 priced months, Mar 2026 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
58.4% now · highest 61.1%, lowest 58.4%
Companies held
29 now · largest single holding 10.2% of equity
How it trades: no clear lean toward recent winners or losers (score -0.13 over 6 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 24 shared73.5%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 18 shared72.4%
- EODWHFEdelweiss · 20 shared72.4%
- DSP Nifty Healthcare Index FundDSP · 18 shared72.4%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 18 shared72.4%
- Axis NIFTY Healthcare ETFAxis · 18 shared72.4%
- DSP Nifty Healthcare ETFDSP · 18 shared72.4%
- Bandhan BSE Healthcare Index FundBandhan · 25 shared65.6%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- None this month.
Complete exits
- None this month.
Largest increases
- 01 Aster DM Quality Care Limited+17.8% +2.52 L
- 02 Dr. Reddy's Laboratories Limited+12.9% +1.57 L
- 03 Symbiotec Pharmalab Limited+33.9% +1.20 L
- 04 Neogen Chemicals Limited+108.1% +1.11 L
- 05 Krishna Institute of Medical Sciences Limited+6.7% +1.00 L
- 06 Biocon Limited+2.7% +50,000
- 07 Alkem Laboratories Limited+12.6% +28,500
- 08 Gland Pharma Limited+7.9% +23,750
- 09 Apollo Hospitals Enterprise Limited+1.8% +4,200
- 10 Dr. Lal Path Labs Ltd.+0.3% +1,483
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 10.15% | 355 Cr | 0.20 Cr | by Mar 2026 (7 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 9.79% | 342 Cr | 0.04 Cr | by Mar 2026 (7 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.80% | 238 Cr | 0.05 Cr | by Mar 2026 (7 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 5.62% | 196 Cr | 0.02 Cr | by Mar 2026 (7 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 5.51% | 193 Cr | 0.10 Cr | by Mar 2026 (7 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 4.84% | 169 Cr | 0.14 Cr | by Mar 2026 (7 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 4.78% | 167 Cr | 0.07 Cr | by Mar 2026 (7 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 3.78% | 132 Cr | 0.08 Cr | by Mar 2026 (7 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 3.76% | 131 Cr | 0.03 Cr | by Mar 2026 (7 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 3.39% | 118 Cr | 0.06 Cr | by Mar 2026 (7 mo+) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 3.39% | 118 Cr | 0.16 Cr | by Mar 2026 (7 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 3.33% | 116 Cr | 0.17 Cr | by Mar 2026 (7 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 3.23% | 113 Cr | 0.07 Cr | by Mar 2026 (7 mo+) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 3.01% | 105 Cr | 0.07 Cr | by Mar 2026 (7 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.94% | 103 Cr | 0.13 Cr | by Mar 2026 (7 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 2.90% | 101 Cr | 0.05 Cr | by Mar 2026 (7 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.69% | 93.92 Cr | 0.03 Cr | by Mar 2026 (7 mo+) |
| Cipla Limited | Healthcare | Large Cap | 2.63% | 92.01 Cr | 0.07 Cr | by Mar 2026 (7 mo+) |
| Eris Lifesciences Limited | Healthcare | Small Cap | 2.39% | 83.38 Cr | 0.07 Cr | by Mar 2026 (7 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 2.35% | 81.96 Cr | 0.09 Cr | by Mar 2026 (7 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 2.27% | 79.21 Cr | 0.04 Cr | by Mar 2026 (7 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.24% | 78.35 Cr | 0.03 Cr | by Mar 2026 (7 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.01% | 70.05 Cr | 0.19 Cr | by Mar 2026 (7 mo+) |
| Molbio Diagnostics Limited | Not classified | — | 1.77% | 61.89 Cr | 0.05 Cr | Aug 2026 (2 mo) |
| Symbiotec Pharmalab Limited | Not classified | — | 1.60% | 55.81 Cr | 0.05 Cr | Aug 2026 (2 mo) |
| Neogen Chemicals Limited | Chemicals | Small Cap | 1.50% | 52.53 Cr | 0.02 Cr | by Mar 2026 (7 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 0.93% | 32.45 Cr | 0.04 Cr | by Mar 2026 (7 mo+) |
| Deepak Nitrite Limited | Chemicals | Small Cap | 0.40% | 14.00 Cr | 91,539 | by Mar 2026 (7 mo+) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 0.00% | 0.04 Cr | 199 | by Mar 2026 (7 mo+) |
Half of its current holdings have been held for 7 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +0.03 Cr |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▼ Reducing | -0.02 Cr |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +0.02 Cr |
| Symbiotec Pharmalab Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Neogen Chemicals Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Anthem Biosciences Limited | Sep 2026 | ▼ Reducing | -70,000 |
| Sai Life Sciences Limited | Sep 2026 | ▼ Reducing | -64,500 |
| Biocon Limited | Sep 2026 | ▲ Increasing | +50,000 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +28,500 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +23,750 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +4,200 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -4,000 |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -2,662 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +1,483 |
| Molbio Diagnostics Limited | Aug 2026 | ▲ New position | +0.05 Cr |
| Symbiotec Pharmalab Limited | Aug 2026 | ▲ New position | +0.04 Cr |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| Biocon Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -0.01 Cr |
| Aster DM Quality Care Limited | Aug 2026 | ▲ Increasing | +0.01 Cr |
| Lupin Limited | Aug 2026 | ▼ Reducing | -76,000 |
| Aurobindo Pharma Limited | Aug 2026 | ▼ Reducing | -43,853 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +40,000 |
| Anthem Biosciences Limited | Aug 2026 | ▼ Reducing | -40,000 |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +40,000 |
| Narayana Hrudayalaya Ltd. | Aug 2026 | ▼ Reducing | -31,662 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +28,500 |
| Sai Life Sciences Limited | Aug 2026 | ▼ Reducing | -25,000 |
| Cipla Limited | Aug 2026 | ▼ Reducing | -25,000 |
| Eris Lifesciences Limited | Aug 2026 | ▼ Reducing | -17,672 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +13,000 |
| Gland Pharma Limited | Aug 2026 | ▲ Increasing | +10,000 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▲ Increasing | +7,950 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -7,000 |
| Onesource Specialty Pharma Limited | Aug 2026 | ▲ Increasing | +6,083 |
| Biocon Limited | Jul 2026 | ▲ Increasing | +0.13 Cr |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -0.09 Cr |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +0.05 Cr |
| Lupin Limited | Jul 2026 | ▼ Reducing | -89,000 |
| Aurobindo Pharma Limited | Jul 2026 | ▼ Reducing | -59,122 |
| Krishna Institute of Medical Sciences Limited | Jul 2026 | ▼ Reducing | -50,000 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▼ Reducing | -46,692 |
| Gland Pharma Limited | Jul 2026 | ▼ Reducing | -35,000 |
| Sai Life Sciences Limited | Jul 2026 | ▼ Reducing | -30,000 |
| Onesource Specialty Pharma Limited | Jul 2026 | ▲ Increasing | +25,000 |
| Laurus Labs Limited | Jul 2026 | ▼ Reducing | -15,000 |
| Mankind Pharma Limited | Jul 2026 | ▲ Increasing | +15,000 |
| Alkem Laboratories Limited | Jul 2026 | ▲ Increasing | +6,000 |
| Sudeep Pharma Limited | Jun 2026 | ▼ Complete exit | -0.02 Cr |
| Max Healthcare Institute Limited | Jun 2026 | ▲ Increasing | +0.01 Cr |
| Onesource Specialty Pharma Limited | Jun 2026 | ▲ Increasing | +0.01 Cr |
| Krishna Institute of Medical Sciences Limited | Jun 2026 | ▲ Increasing | +91,467 |
| Glenmark Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +29,000 |
| Lupin Limited | Jun 2026 | ▼ Reducing | -27,500 |
| Dr. Reddy's Laboratories Limited | Jun 2026 | ▲ Increasing | +25,922 |
| Dr. Lal Path Labs Ltd. | Jun 2026 | ▲ Increasing | +20,000 |
| Gland Pharma Limited | Jun 2026 | ▲ Increasing | +19,438 |
| Narayana Hrudayalaya Ltd. | Jun 2026 | ▼ Reducing | -16,000 |
| Alkem Laboratories Limited | Jun 2026 | ▲ Increasing | +6,000 |
| IPCA Laboratories Limited | Jun 2026 | ▲ Increasing | +5,000 |
| Biocon Limited | May 2026 | ▼ Reducing | -0.06 Cr |
| Dr. Lal Path Labs Ltd. | May 2026 | ▲ Increasing | +60,000 |
| Eris Lifesciences Limited | May 2026 | ▲ Increasing | +59,782 |
| Sudeep Pharma Limited | May 2026 | ▼ Reducing | -46,243 |
| Aster DM Quality Care Limited | May 2026 | ▼ Reducing | -40,000 |
| Mankind Pharma Limited | May 2026 | ▲ Increasing | +40,000 |
| Max Healthcare Institute Limited | May 2026 | ▲ Increasing | +32,500 |
| IPCA Laboratories Limited | May 2026 | ▲ Increasing | +30,927 |
| Rubicon Research Limited | May 2026 | ▼ Complete exit | -30,747 |
| Dr. Reddy's Laboratories Limited | May 2026 | ▲ Increasing | +25,000 |
| Wockhardt Limited | May 2026 | ▼ Complete exit | -21,796 |
| Alkem Laboratories Limited | May 2026 | ▲ Increasing | +10,000 |
| Onesource Specialty Pharma Limited | May 2026 | ▲ Increasing | +6,836 |
| Syngene International Limited | May 2026 | ▼ Complete exit | -2,181 |
| SAGILITY LIMITED | Apr 2026 | ▼ Complete exit | -0.37 Cr |
| Max Healthcare Institute Limited | Apr 2026 | ▲ Increasing | +0.04 Cr |
| Rubicon Research Limited | Apr 2026 | ▼ Reducing | -0.03 Cr |
| Eris Lifesciences Limited | Apr 2026 | ▲ Increasing | +90,456 |
| Aster DM Quality Care Limited | Apr 2026 | ▼ Reducing | -59,200 |
| Cipla Limited | Apr 2026 | ▼ Reducing | -50,000 |
| Dr. Reddy's Laboratories Limited | Apr 2026 | ▲ Increasing | +40,700 |
| Anthem Biosciences Limited | Apr 2026 | ▼ Reducing | -38,309 |
| Glenmark Pharmaceuticals Limited | Apr 2026 | ▼ Reducing | -27,500 |
| Alkem Laboratories Limited | Apr 2026 | ▲ Increasing | +21,999 |
| Dr. Lal Path Labs Ltd. | Apr 2026 | ▲ Increasing | +20,000 |
| Aurobindo Pharma Limited | Apr 2026 | ▼ Reducing | -20,000 |
| Lupin Limited | Apr 2026 | ▼ Reducing | -20,000 |
| Narayana Hrudayalaya Ltd. | Apr 2026 | ▲ Increasing | +16,500 |
| IPCA Laboratories Limited | Apr 2026 | ▲ Increasing | +11,000 |
| Divi's Laboratories Limited | Apr 2026 | ▲ Increasing | +5,000 |
| Sudeep Pharma Limited | Apr 2026 | ▼ Reducing | -1,832 |
| J.B. Chemicals & Pharmaceuticals Lt | Apr 2026 | ▲ Increasing | +1,080 |
| Sun Pharmaceutical Industries Limited | Apr 2026 | ▲ Increasing | +828 |
Changes compare consecutive month-end disclosures for this portfolio only.